Your Chief AI Officer · Monday, November 2, 2026

Medicare's AI prior authorization pilot cut some services by nearly 20%

A JAMA research letter on Medicare's AI-enabled prior authorization pilot and a Pew survey of public views on AI in claims give finance and payer leaders measures to plan around this week. A ransomware settlement, AI-speed vulnerability discovery in robotics software and a new FDA device class shape the risk and procurement agenda. New documentation, imaging and workforce signals point to where administrative work can come off clinicians' desks.

5 items · about 8 minutes · ordered for the Chief Medical Officer and physicians

Read as:EditorChief AI OfficerCEOCOOCFOCIO and CTOCISOCMO (medical)CNOCHROCMO (marketing)CompliancePatient experience

Act today

Insights a leader can act on this week: what happened, the one move to make, and the roles it falls to.

01Study2 sourcesFor patients and employees

Chief AI OfficerCFOCMO (medical)COO

Medicare's AI-enabled prior authorization pilot linked to nearly 20% drop in some services

A research letter published Oct. 26 in JAMA found that in the first six months of Medicare's Wasteful and Inappropriate Service Reduction (WISeR) pilot, use of targeted services fell in participating states relative to the rest of the country. Researchers from the University of Minnesota School of Public Health and Brown University reported a drop of nearly 20% in some services, as covered by Becker's Hospital Review and Becker's Payer Issues.

Do this week. Pull your own volume and authorization data for WISeR-targeted services in participating states and compare it with the JAMA findings before your next payer review. Run this

The evidence.
The JAMA research letter, as reported by Becker's, links the pilot to a nearly 20% relative drop in use of some targeted services over its first six months.

For the Chief Medical Officer and physicians. Ask physician leaders to review whether care in targeted services is being delayed or forgone and document clinical rationale for appeals.

For the Chief AI Officer. Brief the board that AI-enabled prior authorization now has a measured effect on service volume and add WISeR exposure to the AI risk register.

For the CFO and revenue cycle. Model the revenue effect of a relative volume drop on WISeR-targeted services in participating states and adjust forecasts.

Read the full item

Sources:Becker's Hospital ReviewBecker's Payer Issues

02Reported2 sourcesFor patients

Chief AI OfficerCMO (marketing)CompliancePatient experience

Pew finds 46% of Americans oppose AI in insurance claim decisions

A Pew Research Center survey published Oct. 29 found nearly half of U.S. adults oppose AI playing any role in health insurance claim decisions, according to Becker's Payer Issues. The survey of 3,488 adults, conducted in June, tested openness to AI across eight healthcare tasks. Separately, Healthcare IT Today reported that 91% of patients want their permission required when AI is used for diagnosis.

Do this week. Review where your organization discloses AI use to patients and members, starting with claims and diagnosis, and close the gaps. Run this

The evidence.
The Pew survey of 3,488 adults, as reported by Becker's, found 46% oppose any AI role in claim decisions; no independent evidence ties disclosure practices to trust outcomes yet.

For the Chief AI Officer. Add patient disclosure and consent to the AI governance checklist for any tool touching claims or diagnosis.

For the Chief Marketing Officer. Prepare plain-language explanations of how AI is and is not used, so patients hear it from you rather than from a denial letter.

For the Compliance, privacy and legal. Inventory current consent language against AI use in diagnosis and claims and flag where permission is not sought.

For the Patient experience. Brief contact center staff on how to answer patient questions about AI in claims and care decisions.

Read the full item

Sources:Becker's Payer IssuesHealthcare IT Today

03Announced1 sourceFor patients and employees

Chief AI OfficerCMO (marketing)Compliance

OpenAI will honor a shared robots.txt signal for AI training preferences

OpenAI announced it will honor a shared robots.txt signal that lets website operators communicate their AI training preferences to participating providers.

Do this week. Decide whether your organization's patient education and clinical content should be available for AI training and set the robots.txt signal accordingly. Run this

The claim.
OpenAI says the signal helps website operators communicate training preferences to participating providers.
The evidence.
This is a company announcement; no independent evidence of adoption is available yet.

For the Chief AI Officer. Set an organizational position on AI training use of public content and record it in governance policy.

For the Chief Marketing Officer. Weigh whether having your patient content in AI training helps patients find accurate answers or weakens control of your voice.

For the Compliance, privacy and legal. Document the decision on training preferences alongside existing website terms.

Disclosure: OpenAI is one of the enterprise AI platforms Ecofy implements for clients.

Read the full item

Sources:OpenAI News

04Reported2 sourcesFor patients and employees

Chief AI OfficerCFOCompliance

Draft PATIENT AI Act would clarify FDA or ONC oversight and add AI payment pathway

Sen. Bill Cassidy released a discussion draft of the PATIENT AI Act, proposing to clarify whether FDA or ONC oversees healthcare AI tools and to create a federal payment pathway for AI-based services, according to Becker's Hospital Review. Separately, STAT reported that FDA and CMS officials are working to head off conflict as more states look to test AI in clinical settings.

Do this week. Map which of your AI tools would fall under FDA versus ONC oversight and which could qualify for a payment pathway, so you can respond to the draft. Run this

The claim.
The draft proposes to clarify oversight and create a payment pathway for AI-based services.
The evidence.
This is a discussion draft, not law; no outcomes exist.

For the Chief AI Officer. Classify the AI portfolio by likely regulator so the organization can comment on the draft with specifics.

For the CFO and revenue cycle. Identify AI services whose business case would change if a federal payment pathway existed.

For the Compliance, privacy and legal. Track the draft and state sandbox developments in the regulatory calendar.

Read the full item

Sources:Becker's Hospital ReviewSTAT Health Tech

Heard on the podcasts

What Moonshots, All-In, No Priors and the rest said that applies to medicine. Business, science and technology only, never politics.

05Heard1 sourceFor employees

Chief AI OfficerCOOCFO

Robot Report Podcast: humanoids show no ROI yet despite 45 logistics pilots

On The Robot Report Podcast, executive editor Steve Crow quoted GXO's Patrick Kelleher: 45 humanoid pilots so far and no ROI on humanoids yet, a couple of years away. Senior editor Mike Oitzman cited Agility Robotics CFO Michael Beer on a bill of materials of roughly $150,000 per robot at around a thousand units a year, possibly falling to about $30,000 at 10,000 units. Oitzman also reported A3 Q3 North American robot orders up 24.8% in units, with life sciences among segments showing gains.

Ask your team. Ask your operations team what return a humanoid or mobile robot pilot would need to show before you would fund one. Run this

The claim.
GXO's Patrick Kelleher, as quoted on the show, said humanoid ROI is a couple of years away.
The evidence.
These are figures spoken on a podcast, not independent evidence.

For the Chief AI Officer. Hold humanoid proposals to a defined ROI gate given the lack of returns cited in logistics.

For the COO and operations. Focus near-term automation on proven task-specific robots rather than humanoids.

For the CFO and revenue cycle. Use the cited unit cost range to stress-test any humanoid business case.

Read the full item

Sources:The Robot Report Podcast

Less administrative work. Better patient care. A better working life for the people who deliver it. Drafted by Lumen from the named sources above, checked by rule against those sources (every figure, two independent outlets or a primary source) and published only when it passes. A person can pull any item, and corrections are published. Apolitical, always. Nothing here is medical advice. How Your Chief AI Officer is made. Ecofy LLC.

Your Chief AI Officer

What AI and robotics can do for your organization today, and what is coming in thirty days.

Every weekday morning, ordered for your role. Free.

One click to confirm, one click to leave, and you can change your role or cadence any time. Your address stays with Ecofy and is never shared with partners.